Current Prevalence of Helicobacter pylori Resistance to Clarithromycin, Metronidazole, Amoxycillin, Tetracycline and Levofloxacin in Brazil

被引:0
|
作者
Eisig, Jaime N.
Navarro-Rodriguez, Tomas
Barbuti, Ricardo C.
Silva, Fernando M.
Moraes-Filho, Joaquim P.
Zaterka, Schlioma
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:A342 / A343
页数:2
相关论文
共 50 条
  • [41] Amoxycillin or clarithromycin in the eradication of Helicobacter pylori.
    Park, KN
    Park, JY
    Lee, OY
    Jun, YC
    Han, DS
    Sohn, JH
    Yoon, BC
    Choi, HS
    Hahm, JS
    Lee, MH
    Kee, CS
    GASTROENTEROLOGY, 1997, 112 (04) : A252 - A252
  • [42] Prevalence of Helicobacter pylori resistance to clarithromycin in Tunisia
    Chtourou, Lassaad
    Moalla, Manel
    Mnif, Basma
    Smaoui, Hend
    Gdoura, Hela
    Boudabous, Mona
    Mnif, Leila
    Amouri, Ali
    Hammami, Adnene
    Tahri, Nabil
    JOURNAL OF MEDICAL MICROBIOLOGY, 2022, 71 (08)
  • [43] HIGH HELICOBACTER PYLORI RESISTANCE TO CLARITHROMYCIN AND METRONIDAZOLE IN TURKISH CHILDREN
    Cakar, S.
    Ozturk, Y.
    Demiray-Gurbuz, E.
    Becerikli, T.
    Yilmaz, O.
    HELICOBACTER, 2015, 20 : 124 - 124
  • [44] Helicobacter Pylori Resistance to Metronidazole and Clarithromycin in Dyspeptic Patients in Iran
    Tomatari, F. Haghi
    Mobarez, A. Mohabbati
    Amini, M.
    Hosseini, D.
    Abadi, A. Talebi Bezmin
    IRANIAN RED CRESCENT MEDICAL JOURNAL, 2010, 12 (04) : 409 - 412
  • [45] Studies on the development and stability of resistance of Helicobacter pylori to metronidazole and clarithromycin
    Baffone, W
    Pianetti, A
    Citterio, B
    Lombardelli, G
    Vittoria, E
    Bruscolini, F
    JOURNAL OF CHEMOTHERAPY, 2001, 13 (02) : 126 - 132
  • [46] Primary Helicobacter pylori resistance to metronidazole and clarithromycin in the Finnish population
    Koivisto, TT
    Rautelin, HI
    Voutilainen, ME
    Niemelä, SE
    Heikkinen, M
    Sipponen, PI
    Färkkilä, MA
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 19 (09) : 1009 - 1017
  • [47] A randomized trial of lansoprazole, amoxycillin, and clarithromycin versus lansoprazole, bismuth, metronidazole and tetracycline in the retreatment of patients failing initial Helicobacter pylori therapy
    Magaret, N
    Burm, M
    Faigel, D
    Kelly, C
    Peterson, W
    Fennerty, MB
    DIGESTIVE DISEASES, 2001, 19 (02) : 174 - 178
  • [48] Genetic Markers of Helicobacter pylori Resistance to Clarithromycin and Levofloxacin in Moscow, Russia
    Bodunova, Natalia
    Tsapkova, Larisa
    Polyakova, Vera
    Baratova, Irina
    Rumyantsev, Konstantin
    Dekhnich, Natalia
    Nikolskaya, Karina
    Chebotareva, Margarita
    Voynovan, Irina
    Parfenchikova, Elena
    Pronina, Galina
    Chernikova, Ekaterina
    Bordin, Dmitry
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2024, 46 (07) : 6665 - 6674
  • [49] MOLECULAR GENETIC DIAGNOSIS OF HELICOBACTER PYLORI AND ITS RESISTANCE TO CLARITHROMYCIN AND LEVOFLOXACIN
    Tsapkova, L. A.
    Polyakova, V. V.
    Yanova, T. I.
    Mineeva, D. T.
    Bobovskaya, T. A.
    Chegodar, A. S.
    Bordin, D. S.
    Bodunova, N. A.
    TERAPEVTICHESKII ARKHIV, 2022, 94 (02) : 301 - 302
  • [50] Efficacy of a multistep strategy for Helicobacter pylori eradication:: quadruple therapy with omeprazole, metronidazole, tetracycline and bismuth after failure of combination of omeprazole, clarithromycin and amoxycillin
    Díez, JMB
    Mompó, CL
    Rams, FR
    Lareo, MG
    Ibáñez, MRH
    Gila, JT
    MEDICINA CLINICA, 2000, 115 (16): : 617 - 619